Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-03-04 @ 2:59 PM
Study NCT ID:
NCT01457508
Status:
COMPLETED
Last Update Posted:
2017-06-16
First Post:
2011-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-01
Start Date Type:
None
Primary Completion Date:
2000-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2000-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-20
First Submit QC Date:
None
Study First Post Date:
2011-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-15
Last Update Post Date:
2017-06-16
Last Update Post Date Type:
ACTUAL